会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Alkyl sulfonamide derivatives
    • 烷基磺酰胺衍生物
    • US20060293341A1
    • 2006-12-28
    • US11472826
    • 2006-06-21
    • Vrej JubianMathivanan PackiarajanHermogenes JimenezEmily Reinhard
    • Vrej JubianMathivanan PackiarajanHermogenes JimenezEmily Reinhard
    • A61K31/497A61K31/4439C07D417/02
    • C07D417/04
    • This invention is directed to alkyl sulfonamide derivatives which are ligands at the NPY Y5 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression which comprises administering to the subject an amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from anxiety which comprises administering to the subject an amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject an amount of a compound of the subject invention.
    • 本发明涉及作为NPY Y5受体的配体的烷基磺酰胺衍生物。 本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。 本发明还提供通过混合治疗有效量的本发明化合物和药学上可接受的载体制备的药物组合物。 本发明还提供了制备药物组合物的方法,其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。 本发明还提供了治疗患有抑郁症的受试者的方法,其包括给予受试者一定量的本发明化合物。 本发明还提供了治疗患有焦虑症的受试者的方法,其包括给予受试者一定量的本发明化合物。 本发明还提供了治疗患有肥胖症的受试者的方法,其包括给予受试者一定量的本发明化合物。
    • 2. 发明申请
    • Halogenated sulfonamide derivatives
    • 卤代磺酰胺衍生物
    • US20070213376A1
    • 2007-09-13
    • US11714008
    • 2007-03-05
    • Vrej JubianMathivanan PackiarajanEmily Reinhard
    • Vrej JubianMathivanan PackiarajanEmily Reinhard
    • A61K31/44
    • C07D417/04
    • This invention is directed to halogenated sulfonamide derivatives which are ligands at the NPY Y5 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression which comprises administering to the subject an amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from anxiety which comprises administering to the subject an amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject an amount of a compound of the subject invention. Furthermore, the present invention is directed to use of a compound of the invention for the manufacture of a medicament for treating a subject suffering from depression, anxiety or obesity.
    • 本发明涉及作为NPY Y5受体的配体的卤代磺酰胺衍生物。 本发明提供了包含治疗有效量的本发明化合物和药学上可接受的载体的药物组合物。 本发明还提供通过混合治疗有效量的本发明化合物和药学上可接受的载体制备的药物组合物。 本发明还提供了制备药物组合物的方法,其包括将治疗有效量的本发明化合物和药学上可接受的载体组合。 本发明还提供了治疗患有抑郁症的受试者的方法,其包括给予受试者一定量的本发明化合物。 本发明还提供了治疗患有焦虑症的受试者的方法,其包括给予受试者一定量的本发明化合物。 本发明还提供了治疗患有肥胖症的受试者的方法,其包括给予受试者一定量的本发明化合物。 此外,本发明涉及本发明化合物在制备用于治疗患有抑郁,焦虑或肥胖的受试者的药物中的用途。